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Background: It is crucial to identify in large population samples the most important determinants of excessive fetal
growth. The aim of the study was to evaluate the independent role of pre-pregnancy body mass index (BMI), gestational
weight gain and gestational diabetes on the risk of macrosomia.
Methods: A prospective study collected data on mode of delivery and maternal/neonatal outcomes in eleven Hospitals
in Italy. Multiple pregnancies and preterm deliveries were excluded. The sample included 14109 women with complete
records. Associations between exposure variables and newborn macrosomia were analyzed using Pearson’s chi squared
test. Multiple logistic regression models were built to assess the independent association between potential predictors
and macrosomia.
Results: Maternal obesity (adjusted OR 1.7, 95% CI 1.4-2.2), excessive gestational weight gain (adjusted OR 1.9,
95% CI 1.6-2.2) and diabetes (adjusted OR 2.1, 95% CI 1.5-3.0 for gestational; adjusted OR 3.0, 95% CI 1.2-7.6 for
pre-gestational) resulted to be independent predictors of macrosomia, when adjusted for other recognized risk factors.
Since no significant interaction was found between pre-gestational BMI and gestational weight gain, excessive weight
gain should be considered an independent risk factor for macrosomia. In the sub-group of women affected by
gestational or pre-gestational diabetes, pre-gestational BMI was not significantly associated to macrosomia, while
excessive pregnancy weight gain, maternal height and gestational age at delivery were significantly associated.
In this sub-population, pregnancy weight gain less than recommended was not significantly associated to a
reduction in macrosomia.
Conclusions: Our findings indicate that maternal obesity, gestational weight gain excess and diabetes should be
considered as independent risk factors for newborn macrosomia. To adequately evaluate the clinical evolution of
pregnancy all three variables need to be carefully assessed and monitored.
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The incidence of obesity and gestational diabetes (GDM)
is rising worldwide. The prevalence of obesity, defined as a
Body Mass Index (BMI) equal or over 30 Kg/m2, increased
from 12% in 1991 to 17.9% in 1998, in the U.S.A. [1].
Similarly, the overall prevalence of diagnosed gestational
diabetes in the U.S. was less than 6% in 1994, while in
2000 approximately half of the States had a prevalence
equal to 6%. By 2009, only two American States maintained
a similar prevalence while in fifteen States it exceeded
9% [2].
It is already well known that both obesity and GDM are
relative risk factors for adverse maternal and neonatal
outcomes, being related to an increased occurrence of
Large for Gestational Age (LGA) fetuses and macrosomia
(defined as neonates birthweight over 4000 g). Although
macrosomia can be influenced by both genetic and en-
vironmental factors, the rapid increase in prevalence is
mainly attributable to environmental causes [3]. Among
these, maternal overweight and the related metabolic
changes such as diabetes mellitus type 2 and GDM, seem
to be crucially important.
A large number of studies have demonstrated a signifi-
cant association between pre-pregnancy BMI and neo-
natal birthweight [4]. More recent cohort studies have
assessed the effect of gestational weight gain on neonatal
birthweight. The majority of these studies were limited
by small sample sizes or unreliable data collection methods
such as the use of non-validated questionnaires [5,6]. It
is recognized that pre-pregnancy BMI and gestational
weight gain depend on different metabolic pathways. Pre-
pregnancy BMI represents maternal nutritional conditions
before conception, while gestational weight gain is the
expression of fetal-maternal physiological changes com-
bined with genetic and nutritional factors. The fetal
contribution (fetal weight, placenta and amniotic fluid)
accounts for 30-40% of maternal weight gain [7], while
maternal factors (plasmatic volume expansion, breast
and uterine pregnancy growth, maternal fat deposits
available for breastfeeding and extracellular fluid volume)
account for 60-70% [8].
Evidences suggest that maternal diabetes increases the
occurrence of large for gestational age (defined as neonatal
birthweight superior to the 90th percentile) and its contri-
bution may lead to incidence rates as high as 28.5%, as
demonstrated by the DIEP Study in 1991 [9]. Further-
more, macrosomic neonates born to diabetic and over-
weight mothers are exposed to a much higher risk of
developing young age obesity: 17.1% versus 14.2% in the
control group at birth, and 9.7% versus 6.6% at adoles-
cence [10]. A study carried out on a large cohort of preg-
nant women suggested that suboptimal glycemic control
could be an important risk factor for the development of
macrosomia, independently of pre-pregnancy BMI [11].In this context it is crucial to understand which, between
pre-pregnancy BMI and pregnancy weight gain, is the
most important determinant of excessive fetal growth.
Thus, the aim of the present study was to identify in a
large sample of women the most important risk factors de-
termining macrosomia and to evaluate the independent
role of pre-pregnancy BMI, gestational weight gain and
gestational diabetes in increasing the risk of excessive
fetal growth.
Methods
An eighteen-months prospective study collected data
on mode of delivery and maternal/neonatal outcomes
from eleven single-institutional obstetric cohorts in
Friuli Venezia Giulia, a region of North-Eastern Italy
accounting for roughly 10,000 deliveries per year. The
study was conducted in compliance with the Helsinki
Declaration and was approved by the institutional review
board of the coordinating center (Technical Scientific
Committee of the Institute for Maternal and Child
Health - IRCCS “Burlo Garofolo”, Trieste, project 86/05,
February 28, 2007). All women provided written in-
formed consent for the inclusion of their records in the
presentation of summary data. Access to the data was
approved by all hospital trust administrations. Study
methods are described in detail elsewhere [12]. Briefly,
the source institutions were first level departments serving
low risk pregnancies, except for two centers which have
a Neonatal Intensive Care Unit (NICU, second referral
units). We created an ad hoc regional computerized
database considering maternal characteristics, variables
related to pregnancy and mode of delivery. We collected
information on maternal characteristics such as maternal
age, pre-pregnancy BMI, weight gain during pregnancy
and presence of one or more medical or obstetrical
conditions including pre-gestational and gestational dia-
betes. Data on institutional deliveries were prospectively
collected at the time of delivery. To maintain overall
data completeness and accuracy, during the study period
periodical meetings were organized to discuss the results
and provide assistance.
All women were screened for gestational diabetes in
each centre. In three centers, the screening test was
carried out using a two steps procedure: a 50 g Glucose
Challenge Test at first and if positive (values higher
than 140 mg), patients were offered a 75 g Oral Glucose
Tolerance Test. Gestational diabetes was diagnosed if two
out of three glycemic values exceeded 95 mg, 180 mg and
155 mg/dl. In eight centers, gestational diabetes was
screened through a 100 g Oral Glucose Tolerance Test
and diagnosed when any two out of four glycemic values
exceeded 95 mg-180 mg-155 mg-140 mg/dl.
Once gestational diabetes was diagnosed, patients were
recommended to carry out a glycemic profile collecting
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treatment was offered if fasting glucose values exceed
90 mg/dl or postprandial values were superior to 120 mg/dl
in at least 20% of the evaluations carried out within a week.
The Body Mass Index was calculated as weight in kg/
(height in meters)2. Data on height, pre-gestational weight
and weight at delivery were collected for each woman.
Pre-pregnancy BMI was classified using the World Health
Organization criteria as underweight (inferior to 18.5),
normal (18.5 to 24.9), overweight (25.0 to 29.9) and obese
(equal or superior to 30). Pregnancy weight gain was
classified as defined by Institute of Medicine (IOM)
guidelines [13]. According to this statement, recommended
pregnancy weight gain was differentiated based on pre-
pregnancy BMI: 12.5-18.0 kg for underweight women,
11.5-16.0 kg for normal-weight, 7.0-11.5 kg for over-
weight and 4.5.0-9.0 kg for obese [13]. The main study
outcome was macrosomia, defined as a birthweight equal
or above 4000 g, as in previous studies [3-7].
Only cases with a complete collection of the variables
described above were included in the statistical analysis.
Multiple pregnancies were excluded as women were more
likely to gain excess weight and neonatal birthweights
were more likely to be lower than in single pregnancies.
Preterm deliveries were excluded because women were
more likely to gain less weight than in term pregnancies.
Continuous variables were reported as means and
standard deviations, while categorical data as absolute
frequencies and percentages, odds ratios (OR) and rela-
tive 95% confidence intervals (CI). Associations between
exposures and outcome variables were analyzed using
Pearson’s chi squared test. Spearman’s correlation was
used to study the relation of maternal weigh gain and
pre-pregnancy BMI with neonatal birthweight. Two mul-
tiple logistic regression models were built to assess the
independent association of potential predictor variables
of macrosomia both in the whole population and in a
subgroup of women affected by gestational diabetes.
Predictor variables were: maternal age at conception,
maternal diseases (autoimmune and hypertensive disor-
ders), pre-gestational BMI, gestational weight gain, parity,
maternal diabetes, maternal height, gestational age at
delivery, newborn sex. A step-down approach retaining
only significant variables was used. A p-value inferior
to 0.05 was considered as statistically significant.
Results
The sample included 14109 women with complete records.
Mean maternal age at conception was 31.7 years (SD 5.2).
Primiparae accounted for 53.7% of deliveries. At the time
of conception 14.5% of women were overweight and 5%
obese; 29.1% of women gained more weight than recom-
mended by IOM [13] (Table 1). Gestational age at delivery
was beyond 40 weeks in 18.6% of cases. Gestationaldiabetes was diagnosed in 360 women (2.6%). The pro-
portion of macrosomia was 7.6%. Mode of delivery was
cesarean section in 21.4% of cases (Table 1).
Data extracted from this sample showed that pre-
gestational BMI was significantly related to macrosomia
(Table 2). The proportion of macrosomia was 10.4% in
overweight women and 15.7% in obese women com-
pared to 6.9% in normal weight women (Chi square for
trend p < 0.001). Similarly, 12.6% of the offspring of
women with excessive weight gain were macrosomic com-
pared to 6.5% of the offspring of normal weight gain
women (p < 0.001). Among women diagnosed with gesta-
tional diabetes 14.2% gave birth to macrosomic babies
compared to 16.7% among mothers affected by pre-
gestational diabetes and 7.4% among healthy women
(p = 0.032 and p < 0.001 respectively). Other risk factors
significantly related to macrosomia were: parity (9.6%
macrosomic babies among multiparous versus 5.8%
among primiparous; p < 0.001), maternal height (9.7%
among women taller than 165 cm versus 5.6% among
women shorter than 165 cm; p < 0.001) and gestational
age at delivery (16.9% if beyond 40 weeks versus 5.4% if
less than 40 weeks, p < 0.001). Maternal age at delivery
was not significantly associated with macrosomia.
Low weight gain was significantly related to low birth-
weight of the offspring (OR 2.0 for low weight gain versus
recommended weight gain; 95% CI: 1.6 - 2.8; p < 0.001).
Only two women with gestational diabetes gave birth to
low birthweight babies.
Correlation of maternal weigh gain and pre-pregnancy
BMI with neonatal birthweight resulted irrelevant (Spearman’s
correlation rho 0.17 and 0.15, respectively).
A multivariate logistic regression was carried out to
evaluate the independent association between exposure
variables and the outcome macrosomia. Diabetes con-
firmed its role as independent predictor of macrosomia,
with a 2.1-fold increased risk of macrosomia among women
with gestational diabetes compared to women without
diabetes, and of 3.0-fold in women with pre-gestational
diabetes (Table 2).
Obesity was found to be an important independent
predictor of macrosomia: obese women had a 1.7-fold in-
creased risk of developing offspring macrosomia compared
to normal weight women (Adjusted OR 1.7; 95% CI 1.4-
2.2; p < 0.001). Maternal overweight was not significantly
associated to macrosomia, once adjusted for the other risk
factors (Adjusted OR 1.1; 95% CI 0.9-1.3; p = 0.319).
Once adjusted for other risk factors, the odds of de-
veloping macrosomia among women whose weight gain
in pregnancy was more than recommended by IOM
compared to women whose gain was in the recom-
mended range was 1.9 (95% CI 1.6-2.2; p < 0.001).
Maternal height above 165 cm, gestational age at delivery
greater than 40 weeks and male sex of the neonate were
Table 1 Description of the sample (14109 pregnant women)
Variable Mean
or frequency
Maternal age at conception in years, mean (SD) 31.7 (5.2)
Categories of maternal age at conception, number (%)
<20 years 170 (1.2)
20-35 years 10559 (74.8)
36-45 years 3370 (23.9)




Maternal height at conception in cm, mean (SD) 165.5 (6.1)
Categories of maternal height at conception,
number (%)
≤ 165 cm 7461 (52.9)
>165 cm 6648 (47.1)
Maternal weight at conception in kg, mean (SD) 62.1 (11.2)
Maternal BMI at conception, mean (SD) 22.6 (3.8)





Gestational age at delivery in weeks, mean (SD) 39 (1.2)
Categories of gestational age at delivery, number (%)
37-40 weeks 11481 (81.4)
>40 weeks 2628 (18.6)




Maternal weight gain during pregnancy in kg,
mean (SD)
12.9 (4.3)
Categories of maternal weight gain during
pregnancy according to IOM recommendations,
number (%)
Recommended by IOM 5755 (40.8)
< Recommended by IOM 4248 (30.1)
> Recommended by IOM 4106 (29.1)
Mode of delivery, number (%)
Spontaneous 9974 (70.7)
Operative 1119 (7.9)
Cesarean section 3016 (21.4)
Infant birthweight in g, mean (SD) 3377 (430)
Categories of infant birthweight, number (%)
<4000 g 13043 (92.4)
≥4000 g 1066 (7.6)
Table 1 Description of the sample (14109 pregnant women)
(Continued)
Neonates sex, number (%)
Female 7006 (49.7)
Male 7103 (50.3)
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nificant interaction between pre-pregnancy BMI and gesta-
tional weight gain was found.
A subgroup analysis was carried out on women af-
fected by gestational diabetes (Table 3). Among these
patients, pre-gestational BMI was no longer significantly
associated to macrosomia. An excessive pregnancy weight
gain was related to a 2.6-fold increased risk of developing
macrosomia when compared to recommended weight
gain (adjusted OR 2.6; 95% CI 1.2-5.5; p = 0.018). Maternal
height greater than 165 cm (adjusted OR 3.3; 95% CI 1.7-
6.4; p < 0.001) and gestational age at delivery greater than
40 weeks (adjusted OR 4.5; 95% CI 2.0-10.1) were inde-
pendent predictors of newborn macrosomia. Maternal
gestational weight gain lower than recommended was not
significantly associated with a reduction in macrosomia
(adjusted OR 0.8; 95% CI 0.3-1.8; p = 0.541).Discussion
Our findings suggest that maternal obesity, excessive
gestational weight gain and diabetes are independent
valuable predictors of macrosomia, when adjusted for
other recognized risk factors (parity, mother’s height,
gestational age at birth, neonate sex). No significant
interaction was found between pre-gestational BMI and
gestational weight gain. Among women affected by ges-
tational or pre-gestational diabetes, pre-gestational BMI
was no longer significantly associated to macrosomia,
while excessive pregnancy weight gain, maternal height
and gestational age at delivery were independent risk
factors to predict macrosomia. In this population, preg-
nancy weight gain lower than recommended was not
significantly associated with a reduction in macrosomia.
Pre-gestational BMI is a universally recognized factor
affecting fetal growth [14]. In our study, obese women
are more likely to develop offspring macrosomia, with
1.7-fold risk increase compared to normal weight women,
thereby confirming the results of previous published
studies [14,15]. Contrary to what has been previously
suggested [16], our overweight women did not have an
increased risk of developing macrosomia: once results
were adjusted for gestational weight gain and other
recognized risk factors for excessive fetal growth, the
odds of developing macrosomia was 1.1 (95% CI 0.9-
1.3; p = 0.319) compared to normal weight patients. A
Table 3 Subgroup analysis on women with gestational diabetes: crude and adjusted odds ratios of developing
offspring macrosomia
Macrosomia (birthweight ≥ 4000 g)
Crude OR p-value Adjusted OR* p-value
(95% CI) (95% CI)
Gestational weight gain
Recommended by IOM 1 1
> Recommended by IOM 2.3 (1.1 - 4.8) 0.017 2.6 (1.2-5.5) 0.018
< Recommended by IOM 0.9 (0.4 - 2.0) 0.777 0.8 (0.3-1.8) 0.541
Maternal height (cm)
≤165 1 1
>165 2.9 (1.5 - 5.4) <0.001 3.3 (1.7-6.4) <0.001
Gestational age (weeks)
37-40 1 1
>40 3.6 (1.7 - 7.6) <0.001 4.5 (2.0-10.1) <0.001
*Adjusted for pre-gestational BMI, parity, sex of the offspring.
Table 2 Crude and adjusted odds ratios of developing offspring macrosomia
Macrosomia (birthweight >4000 g)
(%) Crude OR p-value Adjusted OR p-value
(95% CI) (95% CI)
Pre-gestational BMI*
18.5-24.9 (6.9) 1 1
<18.5 (2.8) 0.4 (0.3 - 0.6) <0.001 0.5 (0.3-0.7) <0.001
25-29.9 (10.4) 1.6 (1.3 - 1.8) <0.001 1.1 (0.9-1.3) 0.319
≥30 (15.7) 2.5 (2.0 - 3.1) <0.001 1.7 (1.4-2.2) <0.001
Gestational weight gain
Recommended by IOM (6.5) 1 1
< Recommended by IOM (4.1) 0.6 (0.5 - 0.7) <0.001 0.6 (0.5-0.8) <0.001
> Recommended by IOM (12.6) 2.1 (1.8 - 2.4) <0.001 1.9 (1.6-2.2) <0.001
Parity
Primiparous (5.8) 1 1
Multiparous (9.6) 1.7 (1.5 - 1.9) <0.001 2.0 (1.7-2.3) <0.001
Maternal Diabetes
No (7.4) 1 1
Gestational diabetes (14.2) 2.1 (1.5 - 2.8) <0.001 2.1 (1.5-3.0) <0.001
Pre-gestational diabetes (16.7) 2.5 (1.0 - 6.1) 0.032 3.0 (1.2-7.6) 0.023
Maternal height (cm)
≤165 (5.6) 1 1
>165 (9.7) 1.8 (1.6 - 2.1) <0.001 1. 9 (1.6-2.2) <0.001
Gestational age (weeks)
37-40 (5.4) 1 1
>40 (16.9) 3.5 (3.1 - 4.0) <0.001 3. 7 (3.2-4.2) <0.001
Neonate sex
Female (5.0) 1 1
Male (10.1) 2.1 (1.9 - 2.4) <0.001 2.2 (2.0-2.6) <0.001
*Test for Trend: p <0.001.
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among overweight patients, gestational weight gain is a
more crucial factor in increasing the risk of macroso-
mia. In fact, in a recent study by Di Benedetto A et al.,
the incidence of macrosomia among overweight women
with a normal gestational weight gain was around 4.8%,
which is similar to that in normal weight women with
a normal gestational weight gain, while in overweight
patients with excessive weight gain the incidence of
macrosomia was up to 13% [16]. In any case, no continuous
relation was found between pre-gestational BMI and
neonatal birthweight.
Excessive gestational weight gain has been extensively
proven to be an important risk factor for the develop-
ment of macrosomia, independently of pre-gestational
BMI [17,18]. This finding is confirmed by our results,
that support the crucial role of pregnancy weight gain,
according to IOM cut-offs, in determining fetal weight
in the general population, regardless of nutritional and
diabetic status. In our population of pregnant women,
gestational weight gain below the recommended range
was found to be protective with respect to macrosomia
(adjusted OR 0.6; 95% CI 0.5-0.8; p < 0.001), but was also
associated with an increased incidence of low birth-
weight babies (crude OR 2.0 for low weight gain versus
recommended weight gain; 95% CI 1.6-2.8). The observed
association confirmed previously published results, offering
strong evidence to support the association between exces-
sive gestational weight gain and increased fetal growth and,
at the other end of the scale, decreased weight gain and
the development of small for gestational age babies [4,19].
Since we did not find a continuous relation between ma-
ternal weight gain and neonatal weight, the cut-offs defined
by IOM seem to be appropriate in classifying maternal
weight gain.
Since we did not find any significant interaction between
pre-pregnancy BMI and gestational weight gain, excessive
weight gain should be considered as an independent risk
factor for macrosomia for both non-obese and obese
women. These findings are confirmed by another recent
study [17]. Neither of these studies classifies obese women
by severity of disease and this could perhaps explain the
lack of interaction. This represents a limitation of our
study, because the severity of obesity has been proven
to modify the association between gestational weight
gain and fetal growth [20]. In other terms, the more severe
the obesity of a patient the lower tends to be the weight
gained during pregnancy.
Subgroup analysis among women with gestational dia-
betes showed that excessive gestational weight gain played
an independent role in increasing the risk of macrosomia
in this group (adjusted OR 2.6; 95% CI 1.2-5.5). Further-
more in this subgroup of patients, a lower than recom-
mended gestational weight gain did not significantly reducethe risk of developing macrosomia (OR 0.8; 95% CI 0.3-
1.8). These results are in contradiction with previous
findings by other authors, suggesting that a further
reduction in the weight gain recommended by IOM
could decrease the incidence of macrosomia and guaran-
tee optimal neonatal outcome [21,22]. Indeed, some au-
thors have suggested that IOM recommendations do
not respond to the needs of obese women affected by
gestational diabetes and should only be applied to obese,
non-diabetic pregnant patients [22]. In our subgroup
population, pre-pregnancy overweight and obesity were
unrelated to macrosomia, but this result needs to be veri-
fied with a larger population.
A very careful re-assessment of ideal gestational weight
gain among obese women affected by gestational dia-
betes should be carried out, as also suggested by litera-
ture. Although among obese patients, a gestational weight
gain below IOM recommendations was associated with
decreased odds of large for gestational age offspring, it
was also significantly related to increased odds of small
for gestational age neonates [23]. Furthermore, in this
population, women who gained weight according to IOM
guidelines were not exposed to an increased risk of de-
livering a low birthweight infant [24]. Among obese
and overweight women affected by gestational diabetes,
a third trimester weight loss was found to be associated
with decreased odds of macrosomia, but increased odds
of small for gestational age offspring [25]. The most
important limitation of our study consists in the lack of
adjustment for glycemic control, since data on glycemia
were not available. In fact, the study was originally de-
veloped to explore the relationship between mode of
delivery and maternal/neonatal outcomes. For the same
reason, data were not collected on pregnant women
using insulin. Despite this limitation, we believe our
findings offer an important contribution on this matter.
In our population of women with GDM, pre-pregnancy
overweight and obesity are unrelated to macrosomia
and excessive gestational weight gain plays a stronger
role in determining this neonatal outcome. Further-
more, a gestational weight gain less than recommended
does not significantly reduce the risk of developing
macrosomia, thereby suggesting that hypocaloric diets
should be avoided, given the related risk of ketonemic
episodes [26] and the consequent possible negative
effects on the infant’s intelligence [27].
Conclusions
Our findings indicate that maternal obesity, excessive
gestational weight gain and diabetes should be considered
independent risk factors for newborn macrosomia. There-
fore, to adequately evaluate the clinical evolution of preg-
nancy, all three variables need to be carefully assessed
and monitored. In the subgroup of women affected by
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was the main variable related to macrosomia and lower
than recommended weight gain did not significantly
reduce the risk of developing macrosomia.Abbreviations
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